
IndraLab
Statements
sparser
"However, studies on TSC2 −/− MEF demonstrate that TSC2 also potentiates this TSC1 inhibitory effect on S6K1 due to TSC2 antagonistic effect on IRS1 phosphorylation by S6K1 on S302 (and correspondent Serine on IRS2) as well as by repression of S6K1-mediated IRS1 (but not IRS2) gene expression [ xref ]."
reach
"In addition, when mTORC1 is activated, S6K1 could directly phosphorylate Insulin receptor substrate 1 (IRS1; S307 and S636 and S639) and promote its degradation, which subsequently blunts phosphoinositide 3-kinase (PI3K)-AKT activation and its downstream effects such as glucose uptake and glycogen accumulation."
sparser
"We report that, by several criteria, S6K1 does not phosphorylate IRS1 at serine 307 in response to insulin in intact human primary adipocytes: (i) The time-courses for phosphorylation of S6K1 and its phosphorylation of S6 are not compatible with the phosphorylation of IRS1 at serine 307; (ii) A dominant-negative construct of S6K1 inhibits the phosphorylation of S6, without effect on the phosphorylation of IRS1 at serine 307; (iii) The specific inhibitor of S6K1 PF-4708671 inhibits the phosphorylation of S6, without effect on phosphorylation of IRS1 at serine 307."
reach
"These include mammalian target of rapamycin (mTOR)-mediated phosphorylation of IRS1 serine 636 (Ser636) and serine 639 (Ser639), ribosomal S6 kinase 1 (S6K1)-mediated phosphorylation of IRS1 serine 307 [Ser307 (mouse serine 302) (Ser302)] and serine 1101, IkappaB kinase beta (IKKbeta) - and c-Jun N-terminal kinase (JNK)-mediated phosphorylation of IRS1 serine 312 [Ser312 (mouse Ser307)], and protein kinase zeta mediated phosphorylation of IRS1 serine 323 (mouse serine 318)."
reach
"However, studies on TSC2 MEF demonstrate that TSC2 also potentiates this TSC1 inhibitory effect on S6K1 due to TSC2 antagonistic effect on IRS1 phosphorylation by S6K1 on S302 (and correspondent Serine on IRS2) as well as by repression of S6K1-mediated IRS1 (but not IRS2) gene expression [88]."
sparser
"However, other studies have revealed that S6K1-deficient mice on a high fat diet were more insulin sensitive, due to the loss of a negative feedback loop, whereas S6K1 phosphorylates insulin receptor substrate 1 (IRS1) on its insulin resistance phosphorylation site at S307 and S636/S639 in fat, liver and muscle to inhibit insulin signaling (Um et al, xref )."